New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
07:49 EDTSOHUSohu.com August volatility elevated at 50 into Q2
Sohu.com August call option implied volatility is at 50, December is at 39; compared to its 26-week average of 42 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on July 28.
News For SOHU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 27, 2015
14:25 EDTSOHUSohu.com sales missed when excluding Webgame, says Summit Research
Summit Research analyst Henry Guo says Sohu.com's sales in Q2 missed expectations when excluding the Webgame business, which was not included in guidance and will be divested in Q3. The "relatively soft" Q3 guidance is mainly due to gaming business uncertainty and early stage of mobile portal initiatives, Guo tells investors in a post-earnings research note. He keeps a Hold rating on Sohu.com with a $50 price target, but thinks the Sogou initial public offering is likely this year and could help unlock value.
09:21 EDTSOHUOn The Fly: Pre-market Movers
HIGHER: Magnetek (MAG), up 53.5% after Columbus McKinnon (CMCO) agrees to acquire the company... Xueda Education (XUE), up 40.6% after merging with Xiamen Insight Investment... Box (BOX), up 4.6% after being upgraded to Overweight from Sector Weight at Pacific Crest... Goodrich Petroleum (GDP), up 6.4% after announcing sale of proved reserves and a portion of Eagle Ford leasehold. NOTABLE: Teva Pharmaceutical (TEVA), up 10.7% after acquiring Allergan Generics... Allergan (AGN) is up 6.3%... Mylan (MYL), down 14% after Teva withdraws proposal to acquire the company... Perrigo (PRGO), up 3% after Teva withdraws proposal to acquire Mylan. DOWN AFTER EARNINGS: Sohu.com (SOHU), down 6%... Changyou.com (CYOU), down 10.1%. ALSO LOWER: Bellerophon (BLPH) down 63% after announcing results of BCM clinical trial... Terex (TEX), down 4% after being downgraded to Sell from Neutral at Goldman... Ultragenyx Pharmaceutical (RARE), down 3.5% after being downgraded to Equal Weight from Overweight at Morgan Stanley...
05:35 EDTSOHUSohu.com sees Q3 EPS (55c)-(80c), consensus (39c)
Sees Q3 revenue $470M-$500M, consensus $530.17M.
05:34 EDTSOHUSohu.com reports Q2 adjusted EPS (37c), may not compare to consensus (80c)
Subscribe for More Information
July 24, 2015
13:12 EDTSOHUSohu.com technical notes ahead of earnings news
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use